NOVABAY PHARMACEUTICALS INC - COM (NBY)

CUSIP: 66987P102

Q1 2015 13F Holders as of 31 Mar 2015

Type / Class
Equity / COM
Total 13F shares
4,517,525
Share change
+1,851,760
Total reported value
$3,051,000
Price per share
$0.69
Number of holders
18
Value change
+$1,215,786
Number of buys
7
Number of sells
7

Quarterly Holders Quick Answers

What is CUSIP 66987P102?
CUSIP 66987P102 identifies NBY - NOVABAY PHARMACEUTICALS INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of NOVABAY PHARMACEUTICALS INC - COM (NBY) as of Q1 2015

As of 31 Mar 2015, NOVABAY PHARMACEUTICALS INC - COM (NBY) was held by 18 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 4,517,525 shares. The largest 10 holders included Frigate Ventures LP, VANGUARD GROUP INC, SUSQUEHANNA INTERNATIONAL GROUP, LLP, Orbitronix, LP, GLENMEDE TRUST CO NA, Polar Securities Inc., WEDBUSH SECURITIES INC, RENAISSANCE TECHNOLOGIES LLC, DEUTSCHE BANK AG\, and GEODE CAPITAL MANAGEMENT, LLC. This page lists 18 institutional shareholders reporting positions in this security for the Q1 2015 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.